Skip to main content

Mental Health Disorder

0
Pipeline Programs
5
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Impact Therapeutics
Impact TherapeuticsChina - Shanghai
1 program
Modified Health Policy ProjectN/A1 trial
Active Trials
NCT05415891Unknown333Est. Jun 2023
Design Therapeutics
1 program
StayOk web applicationN/A
Design Pharmaceuticals
1 program
StayOk web applicationN/A1 trial
Active Trials
NCT03213327Completed174Est. Jul 2019
Applied Medical
Applied MedicalCA - Rancho Santa Margarita
1 program
StayOk web applicationN/A
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Vira mobile app interventionN/A1 trial
Active Trials
NCT05638516Completed73Est. May 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Novo NordiskVira mobile app intervention
Impact TherapeuticsModified Health Policy Project
Design PharmaceuticalsStayOk web application

Clinical Trials (3)

Total enrollment: 580 patients across 3 trials

NCT05638516Novo NordiskVira mobile app intervention

Improving Mental Health in Youth and Lowering Risk for Obesity Through a Digital Preventative Product

Start: Nov 2022Est. completion: May 202373 patients
N/ACompleted
NCT05415891Impact TherapeuticsModified Health Policy Project

The IMPROV Project: Improving Mental Health and Substance Use Treatment Provision (IMPROV) Among People Living With HIV (Human Immunodeficiency Virus) in Atlanta

Start: Jun 2022Est. completion: Jun 2023333 patients
N/AUnknown
NCT03213327Design PharmaceuticalsStayOk web application

StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks

Start: Jul 2017Est. completion: Jul 2019174 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.